Khamaisi M, Kavel O, Rosenstock M, Porat M, Yuli M, Kaiser N, Rudich A
Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva IL-84105, Israel.
Biochem J. 2000 Jul 15;349(Pt 2):579-86. doi: 10.1042/bj3490579.
Decreased cellular GSH content is a common finding in experimental and human diabetes, in which increased oxidative stress appears to occur. Oxidative stress has been suggested to play a causative role in the development of impaired insulin action on adipose tissue and skeletal muscle. In this study we undertook to investigate the potential of GSH depletion to induce insulin resistance, by utilizing the GSH synthesis inhibitor, L-buthionine-[S,R]-sulfoximine (BSO). GSH depletion (20-80% in various tissues), was achieved in vivo by treating rats for 20 days with BSO, and in vitro (80%) by treating 3T3-L1 adipocytes with BSO for 18 h. No demonstrable change in the GSH/GSSG ratio was observed following BSO treatment. GSH depletion was progressively associated with abnormal glucose tolerance test, which could not be attributed to impaired insulin secretion. Skeletal muscle insulin responsiveness was unaffected by GSH depletion, based on normal glucose response to exogenous insulin, 2-deoxyglucose uptake measurements in isolated soleus muscle, and on normal skeletal muscle expression of GLUT4 protein. Adipocyte insulin responsiveness in vitro was assessed in 3T3-L1 adipocytes, which displayed decreased insulin-stimulated tyrosine phosphorylation of insulin-receptor-substrate proteins and of the insulin receptor, but exaggerated protein kinase B phosphorylation. However, insulin-stimulated glucose uptake was unaffected by GSH depletion. In accordance, normal adipose tissue insulin sensitivity was observed in BSO-treated rats in vivo, as demonstrated by normal inhibition of circulating non-esterified fatty acid levels by endogenous insulin secretion. In conclusion, GSH depletion by BSO results in impaired glucose tolerance, but preserved adipocyte and skeletal muscle insulin responsiveness. This suggests that alternative oxidation-borne factors mediate the induction of peripheral insulin resistance by oxidative stress.
细胞内谷胱甘肽(GSH)含量降低在实验性糖尿病和人类糖尿病中均很常见,而这两种情况中似乎都会出现氧化应激增加。氧化应激被认为在脂肪组织和骨骼肌胰岛素作用受损的发展过程中起到了致病作用。在本研究中,我们通过使用GSH合成抑制剂L-丁硫氨酸-[S,R]-亚砜胺(BSO)来研究GSH耗竭诱导胰岛素抵抗的可能性。通过用BSO处理大鼠20天在体内实现了GSH耗竭(各组织中降低20%-80%),并通过用BSO处理3T3-L1脂肪细胞18小时在体外实现了GSH耗竭(80%)。BSO处理后未观察到GSH/GSSG比值有明显变化。GSH耗竭逐渐与异常的葡萄糖耐量试验相关,这不能归因于胰岛素分泌受损。基于对外源胰岛素的正常葡萄糖反应、分离的比目鱼肌中2-脱氧葡萄糖摄取测量以及GLUT4蛋白在正常骨骼肌中的表达,骨骼肌胰岛素反应性不受GSH耗竭的影响。在3T3-L1脂肪细胞中评估了体外脂肪细胞胰岛素反应性,这些细胞显示胰岛素刺激的胰岛素受体底物蛋白和胰岛素受体的酪氨酸磷酸化降低,但蛋白激酶B磷酸化增强。然而,胰岛素刺激的葡萄糖摄取不受GSH耗竭的影响。相应地,在体内用BSO处理的大鼠中观察到正常的脂肪组织胰岛素敏感性,这通过内源性胰岛素分泌对循环中非酯化脂肪酸水平的正常抑制得以证明。总之,BSO导致的GSH耗竭会导致葡萄糖耐量受损,但脂肪细胞和骨骼肌胰岛素反应性得以保留。这表明其他由氧化产生的因素介导了氧化应激诱导的外周胰岛素抵抗。